Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinchai Granules
- Development stage
- Unknown
- Lead developer
- Chengdu Yongkon Pharmacy
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Yinchai Granules (银柴颗粒) is a traditional Chinese medicine (TCM) formulation developed by Chengdu Yongkon Pharmacy. It is approved in China for the treatment of wind-heat common cold, fever, and cough. The formulation is composed of several herbal ingredients, including Lonicerae Japonicae Caulis (honeysuckle stem), Bupleuri Radix (thorowax root), Eriobotryae Folium (loquat leaf), Menthae Haplocalycis Herba (peppermint), and Phragmitis Rhizoma (reed rhizome). Yinchai Granules function by clearing heat, resolving the exterior, and relieving cough.
- Other names
- Yinchai Keli银柴颗粒
Beyond the preview
Go deeper on Yinchai Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yinchai Granules.